Where clinical expertise becomes clinical guidance

ClinicalPath treatment pathways are built by practicing oncologists. Every quarter, a national committee of physicians — spanning academic medical centers and a broad range of practice settings — reviews new FDA approvals, pivotal trial data, and emerging evidence to reach consensus on what belongs on the pathway. The result is guidance that is evidence-based, peer-validated, and designed to support consistent, high-quality care across every clinical setting. In this paper, three committee members share firsthand perspectives on how the process works, why the guidance it produces can be trusted, and what they gain from participating — from staying current on emerging clinical trials to shaping the standard of care for patients they'll never personally treat.